Live Breaking News & Updates on Endometrial Cancer Molecularly Targeted Therapy Consortium

Stay updated with breaking news from Endometrial cancer molecularly targeted therapy consortium. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Molecularly Targeted Therapy May Improve Survival in Advanced, Recurrent Endometrial Cancer

Real-world data suggest that matched, targeted therapy may improve survival in patients with advanced or recurrent endometrial cancer. ....

North Carolina , United States , Duke University Medical Center , Roche Genentech , Angeles Alvarez Secord , Alvarez Secord , Endometrial Cancer Molecularly Targeted Therapy Consortium , National Cancer Trial Network , Cancer Therapy Advisor , National Cancer Trial ,